Oncology biosimilars market to reach $21.28 billion by 2030 at 13.5% cagr, driven by expiration of patents of biologics used for cancer treatment.
Read More
Oncology adjuvants market to reach $2.54 billion by 2030 at 7.9% cagr, driven by increasing demand for personalized medicine.
Read More
Oncogene inhibitor market to reach $65.45 billion by 2030 at 8.6% cagr, driven by increase in the prevalence of cancer.
Read More
Onchocerciasis treatment market to reach $1.59 billion by 2030 at 7.4% cagr, driven by rise in patients suffering from eye-associated issues and increasing demand for surgical procedures.
Read More
Omega-3 supplements market to reach $17.21 billion by 2030 at 11.7% cagr, driven by rising prevalence of cardiovascular diseases.
Read More
Omega 3 prescription drugs market to reach $2.81 billion by 2030 at 10.0% cagr, driven by rising cases of cardiovascular diseases.
Read More
Oligonucleotide therapy market to reach $10.87 billion by 2030 at 12.0% cagr, driven by government initiatives for research and development in healthcare.
Read More
Olanzapine market to reach $3.11 billion by 2030 at 3.6% cagr, driven by increasing prevalence of emotional illness and mental troubles.
Read More
The global octreotide market to reach $3.26 billion by 2030 at 4.9% cagr, driven by increasing rates of cancer.
Read More
Occupational medicines market to reach $7.61 billion by 2030 at 7.1% cagr, driven by increasing prevalence of chronic diseases among the working population.
Read More